Member Info for Newuncle

In that case how and why were cpx successful in 2 previous infringement cases? Facts only please

Pointless arguing now.

Cpx will have the weekend to prepare their market update as will their brokers. Confident they will provide proper guidance on all.

Just wrong assumption the case was related to USA sales by Maxwell only. Nothing related to others already won in court.

Only for the Maxwell IP infringement claim.

This case was only re Maxwell not the others .

Now was that plan B for losing Maxwells licence infringement...OR for Cap-xx losing its patents? No

AVX, lexus, CDE will be discussing suing Cap-xx for there money back? No

They will certainly not be paying any more licence fees. No

So either an appeal or Maxwell buyout for peanuts? No

This is terrible news. No

Cavendish

CAP-XX* Tax rebate received and JV signed CAP-XX has announced the Australian Taxation Office has approved the FY23 R&D grant and associated rebate of A$2.1m. The net proceeds of A$1.0m, after repaying the principal and interest associated with the revolving line of credit drawdown, were received by CAP-XX last week. - Ionic JV signed – CAP-XX has announced it has formally signed a JV vehicle and shareholders agreement with Ionic Industries Ltd for the exclusive commercialisation of Ionic's reduced graphene oxide technology to increase electrode density in supercapacitors. The final terms of this are consistent with the original term sheet of the JV announced on 4 May 2023. - Distribution strategy progressing – CAP-XX has also announced its new distribution strategy continues to progress, with the appointment of a further European distributor, in addition to one in India and two in South Africa. New sales and application opportunities have already been identified by these distributors and purchase orders are anticipated to be received in the coming weeks. The Company is also in the final stages of negotiation with additional distributors and sales representatives and these appointments will be announced once the terms are agreed. - Funded even on current run rates – The receipt of the R&D tax credit is good news and helps bolster the cash balance before the conclusion of the IP Infringement case with Maxwell/Tesla, which is set for hearing from 11-15 December. Whilst we still anticipate a positive outcome, based on the historically successful defence of the same IP infringement with AVX, we estimate that CAX-XX is funded through FY24E without an IP infringement settlement or award, even on a downside scenario. As previously reported, we estimate a downside revenue scenario for FY24E based on the revenue run rate for the first four months of the year is around A$5m. Using our current modelling of costs, this would imply a potential EBITDA loss for the full year of cA$1.5m, which would be covered by a cash balance of A$0.5m four months into FY24E (as per the AGM statement) plus the net A$1m R&D rebate announced today, although additional legals costs (potentially in the range of A$200-250k) will make this cash position tighter. However, we believe revenue expectations by the new management will likely be set between this downside scenario (A$5m) and our current expectations (A$7m), with this to be established after the completion of the CEO’s sales pipeline analysis which is due soon. Looking further ahead, we see the signing of the JV with Ionic a positive indicator.

Yes they do

December 15, 2023

Tesla Unit Dodges Patent Claims Over Supercapacitor Tech

A Delaware jury found Friday that Tesla subsidiary Maxwell Technologies did not infringe two patents owned by Australian company CAP-XX on technology used in energy storage devices, and that Maxwell had shown that many of the claims are invalid.

Ignoring the court case, CPX is on track to deliver:

CAP-XX has also announced its new distribution strategy continues to progress, with the appointment of a further European distributor, in addition to one in India and two in South Africa. New sales and application opportunities have already been identified by these distributors and purchase orders are anticipated to be received in the coming weeks. The Company is also in the final stages of negotiation with additional distributors and sales representatives and these appointments will be announced once the terms are agreed.

And yet still the nervous sell even at this late stage. Oh well it is Friday and many traders don't hold over the weekend for obvious reasons on many shares.

Red or Black on Monday, so

Do You Feel Lucky?

We do Ya?

Funded even on current run rates – The receipt of the R&D tax credit is good news and helps bolster the cash balance before the conclusion of the IP Infringement case with Maxwell/Tesla, which is set for hearing from 11-15 December. Whilst we still anticipate a positive outcome, based on the historically successful defence of the same IP infringement with AVX, we estimate that CAX-XX is funded through FY24E without an IP infringement settlement or award, even on a downside scenario. As previously reported, we estimate a downside revenue scenario for FY24E based on the revenue run rate for the first four months of the year is around A$5m. Using our current modelling of costs, this would imply a potential EBITDA loss for the full year of cA$1.5m, which would be covered by a cash balance of A$0.5m four months into FY24E (as per the AGM statement) plus the net A$1m R&D rebate announced today, although additional legals costs (potentially in the range of A$200-250k) will make this cash position tighter. However, we believe revenue expectations by the new management will likely be set between this downside scenario (A$5m) and our current expectations (A$7m), with this to be established after the completion of the CEO’s sales pipeline analysis which is due soon. Looking further ahead, we see the signing of the JV with Ionic a positive indicator that its materials are helping achieve a material uplift in product performance and that, following a period of supply chain qualification and product testing, new products under this JV could be with customers in CY25. We iterate our view that the turnaround at CAP-XX is showing its first green shoots, the company looks funded through FY24E, with potentially significant upside from the IP infringement, and with new products in the pipeline, we believe the future is looking increasingly positive.

As for Openspaces, I have never come across anyone like him on any share. Constantly talks it down but refuses to exit. If I was that unhappy I would exited years ago but he clings on like a limpet to this BB like some kind of security blanket. I don't think I have ever seen have anything positive to say about CPX or its management. Just comes across as a very grumpy old man, sorry Open but you do. Not a troll in by any means, but a very glass half empty poster here for years and year and years.

Actually we have plenty of clues on the likely outcome of the court court, just look at history of previous cases where CPX won their IP infringement claims. Sales will have improved under the new CEO and via new sales channels, Purchase Orders confirming these are due any day. Other new channels have only just been brought on in S Africa, India etc. New Global IPs confirmed. You make it sound like the SP is over valued at current prices, is that your point? Broker Targeting 7p here (time will tell on that) but plenty of upside here after hitting ground zero below 1p.

All IMO and WTFDIK.

Decision day for people here......buy/hold/sell......classic AIM dilema ahead of new release next week (or even perhaps later today).

Sellers about, always happens when a rising share gets close to a nice round number (2p in this case).

Let 'em go and let MMs dick around as they shake the tree for now.

18p? That's huge?

Well fwiw I am calling the bottom on these now.

Bring on the buyers and milestone payments which will be significant in Q1 2024.

I can wait and have the patience to outlast the short term girations here.

Good Luck to all genuine investors here for 2024.

Yes, but still very odd all the same.

Deja Vu